MicroRNA-421 Improves Ischemia/Reperfusion Injury via Regulation Toll-Like Receptor 4 Pathway

Journal of International Medical Research- United Kingdom

doi 10.1177/0300060519871863

Full Text

Abstract

Available in

Date

Authors

Publisher

SAGE Publications

Related search

MicroRNA‑451 Relieves Inflammation in Cerebral Ischemia‑reperfusion via the Toll‑like Receptor 4/MyD88/NF‑κB Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019Latin

Toll-Like Receptor 4 Is Protective Against Neonatal Murine Ischemia-Reperfusion Intestinal Injury

Journal of Pediatric Surgery
MedicineChild HealthSurgeryPediatricsPerinatology
2010English

Alveolar Macrophages and Toll-Like Receptor 4 Mediate Ventilated Lung Ischemia Reperfusion Injury in Mice

Anesthesiology
AnesthesiologyPain Medicine
2012English

On the Edge: Targeting Toll-Like Receptor 2 in Ischemia/Reperfusion Injury

Circulation: Cardiovascular Interventions
Cardiovascular MedicineCardiology
2012English

Hypoxia Exacerbates Inflammatory Acute Lung Injury via the Toll-Like Receptor 4 Signaling Pathway

Frontiers in Immunology
AllergyImmunology
2018English

Negative Regulation of Toll-Like Receptor 4 Signaling by IL-10-dependent microRNA-146b

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

Impact of Toll-Like Receptor 4 Deficiency on the Response to Uterine Ischemia/Reperfusion in Mice

Reproduction
Cell BiologyGynecologyEndocrinologyReproductive MedicineObstetricsEmbryology
2013English

Toll-Like Receptor 7 Involves the Injury in Acute Kidney Ischemia/Reperfusion of STZ-induced Diabetic Rats

Acta Cirurgica Brasileira
Surgery
2016English

2422Nanoparticle-Mediated Delivery of Toll-Like Receptor 4 Antagonist to Monocytes and Ischemic Myocardium Enhances Cardioprotection Against Ischemia-Reperfusion Injury in Mice

European Heart Journal
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy